Fintel reports that on October 8, 2024, HC Wainwright & Co. upgraded their outlook for Cassava Sciences (NasdaqCM:SAVA) from ...

Fintel reports that on October 7, 2024, HC Wainwright & Co. initiated coverage of DiaMedica Therapeutics (NasdaqCM:DMAC) with ...

Pharming Group (NASDAQ:PHAR – Get Free Report)‘s stock had its “buy” rating restated by research analysts at HC Wainwright in a research note issued to investors on Thursday, Benzinga reports. They ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 65.69% ...

Cassava Sciences (SAVA) stock earns its only buy rating on Wall Street as H.C. Wainwright upgrades the stock citing the company's recent SEC settlement. Read more here.

Equities research analysts at HC Wainwright lowered their Q3 2024 earnings per share estimates for Rhythm Pharmaceuticals in ...

Vir Biotechnology, Inc. (NASDAQ:VIR) today announced that Mark Eisner, M.D., M.P.H., Executive Vice President and Chief ...

30, 2024 (GLOBE NEWSWIRE) -- BitFuFu, Inc. (NASDAQ: FUFU, FUFU.WS) (“BitFuFu” or the “Company”) a fast-growing digital asset mining service and world-leading cloud-mining service provider, today ...

Detailed price information for Madrigal Pharmaceuticals Inc (MDGL-Q) from The Globe and Mail including charting and trades.

WARMINSTER, Pa., Oct. 01, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ABUS), (“Arbutus” or the “Company”), a clinical-stage ...

RCI Hospitality Holdings (NASDAQ: RICK) has received a reaffirmed Buy rating and a $98.00 price target from H.C. Wainwright. The endorsement comes despite the company reporting a slight decrease in ...

Fintel reports that on October 7, 2024, HC Wainwright & Co. initiated coverage of DiaMedica Therapeutics (NasdaqCM:DMAC) with a Buy recommendation. As of September 25, 2024, the average one-year ...